This study aims to evaluate the persistence of anti-poliovirus antibodies in toddlers aged 18
months who were primed with oral polio vaccine (OPV) or inactivated polio vaccine (IPV) in
the primary study. The study will also assess the immunogenicity and reactogenicity of a
booster dose of IPV in subjects primed with three doses of IPV.